Xiaojia Huang - Concepedia

Author

Xiaojia Huang

Also Known As

Bo Chen, Lijuan Zhang, X-J Huang, X. Huang, X.-J. Huang, Xiao-Jia Huang, Xiao-jia Huang, Xiaojia Huang, Xing Li, Xinhua Xie

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Sun Yat-sen University Sun Yat-sen University Cancer Center State Key Laboratory of Oncology in South China The First Affiliated Hospital, Sun Yat-sen University Guangzhou Medical University

About

Xiaojia Huang is an author at Sun Yat-sen University specializing in tumor biology, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	147
2	Cell Biology	2	2	110
3	Health Sciences	1	1	37
4	Immunology	1	1	37
5	Pathology	1	1	37

Xiaojia Huang

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression Bo Chen, Weidong Wei, Xiaojia Huang, Theranostics	2018	299
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer Hailin Tang, Xiaojia Huang, Jin Wang, Molecular Cancer	2019	225
High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer Xiaojia Huang, Xing Li, Xinhua Xie, The Breast	2016	143
The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer Xiangsheng Xiao, Xiaojia Huang, Feng Ye, Scientific Reports	2016	134
PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a Xiaojia Huang, Xinhua Xie, Hua Wang, Journal of Experimental & Clinical Cancer Research	2017	88
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer Bo Chen, Jin Wang, Danian Dai, Journal of Experimental & Clinical Cancer Research	2017	74
SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer Peng Liu, Hailin Tang, Cailu Song, Frontiers in Pharmacology	2018	73
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK Peng Liu, Feng Ye, Xinhua Xie, Oncotarget	2016	71
Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a Xiaojia Huang, Xinhua Xie, Peng Liu, Oncogene Transcriptional RegulationLnc015192 ActGeneticsRna BiologyCancer Cell Biology	2018	70
The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment Jiahuai Wen, Yanning Yang, Feng Ye, The Breast	2015	67

Page 1